| # | Ticker | Company | Price | Chg % | Mkt Cap | P/E | EPS Growth TTM | Div Yield | Sector | Return 1Y | Revenue Growth… | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Caris Life Sciences, Inc. | $17.47 | -1.9% | $4.94B | -9.2 | -122.4% | — | Healthcare | -34.2% | 133.7% | ||
| 2 | Veracyte, Inc. | $56.16 | -3.2% | $4.48B | 68.5 | 164.1% | — | Healthcare | 113.2% | 16.9% | ||
| 3 | Adaptive Biotechnologies Corporation | $20.82 | -3.2% | $3.33B | -53.4 | 65.5% | — | Healthcare | 77.3% | 55.9% | ||
| 4 | Nautilus Biotechnology, Inc. | $1.69 | -1.7% | $215M | -3.6 | 14.8% | — | Healthcare | 112.3% | — | ||
| 5 | Insight Molecular Diagnostics Inc. | $4.93 | -12.6% | $132M | -3.0 | 57.1% | — | Healthcare | 62.7% | -49.3% | ||
| 6 | Seer, Inc. | $2.22 | 1.4% | $122M | -1.7 | 10.8% | — | Healthcare | 1.8% | -0.9% | ||
| 7 | Ainos, Inc. | $1.88 | -7.8% | $9M | -0.5 | 98.6% | — | Healthcare | -43% | -82.9% | ||
| 8 | Aspire Biopharma Holdings, Inc. | $5.61 | -4.6% | $8M | -0.3 | 73.2% | — | Healthcare | -98.4% | — | ||
| 9 | YD Bio Limited Ordinary Shares | $2.00 | -14.5% | $8M | -3.6 | — | — | Healthcare | -83.4% | — | ||
| 10 | Cardio Diagnostics Holdings, Inc. | $1.91 | -4% | $4M | -0.5 | -16.9% | — | Healthcare | -49.6% | -16.8% | ||
| 11 | Virax Biolabs Group Limited | $3.04 | -2.3% | $579181 | -0.1 | 40.6% | — | Healthcare | -85.9% | 1225.8% | ||
| 12 | Aspire Biopharma Holdings, Inc. | $0.02 | 0% | $29899 | -0.0 | 73.2% | — | Healthcare | -50% | — | ||
| 13 | YD Bio Limited Warrants | $0.21 | -34% | — | — | — | — | Healthcare | -61.3% | — |